SLC6A4, solute carrier family 6 member 4, 6532

N. diseases: 440; N. variants: 28
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs25531
rs25531
Entrez Id: 6532;105371720
Gene Symbol: SLC6A4;LOC105371720
SLC6A4;LOC105371720
CUI: C0233514
Disease:
Abnormal behavior
0.050 GeneticVariation BEFREE We investigated, in a large cohort of 5,608 controls and subjects suffering from various psychiatric disorders, the frequency of haplotypes and corresponding genotypes combining the 5-HTTLPR and the other serotonin transporter promoter functional variant (rs25531). 20862697 2010
dbSNP: rs25531
rs25531
Entrez Id: 6532;105371720
Gene Symbol: SLC6A4;LOC105371720
SLC6A4;LOC105371720
CUI: C0233514
Disease:
Abnormal behavior
0.050 GeneticVariation BEFREE Comparing the genotypic and allelic frequencies of AD without and with BPSD, we did not find a difference for the 5-HTTLPR or the rs25531, even after stratification according to single SBI-BP item. 19625753 2009
dbSNP: rs25531
rs25531
Entrez Id: 6532;105371720
Gene Symbol: SLC6A4;LOC105371720
SLC6A4;LOC105371720
CUI: C0233514
Disease:
Abnormal behavior
0.050 GeneticVariation BEFREE SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p<sub>d</sub> = 9.25 × 10<sup>-03</sup>, p<sub>r</sub> = 7.24 × 10<sup>-03</sup>; rs2066713 p<sub>d</sub> = 6.35 × 10<sup>-08</sup>; rs25531 p<sub>d</sub> = 2.95 × 10<sup>-02</sup>; rs4251417 p<sub>d</sub> = 2.46 × 10<sup>-03</sup>), and ALZ (rs6354 p<sub>r</sub> = 1.22 × 10<sup>-02</sup>; rs7224199 p<sub>d</sub> = 1.00 × 10<sup>-08</sup>, p<sub>r</sub> = 2.65 × 10<sup>-02</sup>) cohorts. 31595439 2020
dbSNP: rs25531
rs25531
Entrez Id: 6532;105371720
Gene Symbol: SLC6A4;LOC105371720
SLC6A4;LOC105371720
CUI: C0233514
Disease:
Abnormal behavior
0.050 GeneticVariation BEFREE Subgroups based on the age of OCD onset, gender, familiality, factor analysis-derived symptom dimensions, or comorbidity with other psychiatric disorders failed to identify SLC6A4- or BDNF-associated phenotypes, with one exception of overall number of comorbid anxiety disorders being significantly associated with 5-HTTLPR/rs25531. 17375136 2007
dbSNP: rs25531
rs25531
Entrez Id: 6532;105371720
Gene Symbol: SLC6A4;LOC105371720
SLC6A4;LOC105371720
CUI: C0233514
Disease:
Abnormal behavior
0.050 GeneticVariation BEFREE Rs25532 CC genotype showed significant association with OCD in men and were detected more in the patients reported positive family history of psychiatric disorders but the other single loci (5-HTTLPR and rs25531) did not associate with OCD. 28691545 2018
dbSNP: rs2066713
rs2066713
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
CUI: C0233514
Disease:
Abnormal behavior
0.010 GeneticVariation BEFREE SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p<sub>d</sub> = 9.25 × 10<sup>-03</sup>, p<sub>r</sub> = 7.24 × 10<sup>-03</sup>; rs2066713 p<sub>d</sub> = 6.35 × 10<sup>-08</sup>; rs25531 p<sub>d</sub> = 2.95 × 10<sup>-02</sup>; rs4251417 p<sub>d</sub> = 2.46 × 10<sup>-03</sup>), and ALZ (rs6354 p<sub>r</sub> = 1.22 × 10<sup>-02</sup>; rs7224199 p<sub>d</sub> = 1.00 × 10<sup>-08</sup>, p<sub>r</sub> = 2.65 × 10<sup>-02</sup>) cohorts. 31595439 2020
dbSNP: rs3813034
rs3813034
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
CUI: C0233514
Disease:
Abnormal behavior
0.010 GeneticVariation BEFREE rs3813034 is a functional polymorphism in the serotonin transporter that alters the balance of the two polyadenylation forms of the serotonin transporter. rs3813034 is a putative risk factor for PD and other behavioral disorders that involve dysregulation of serotonergic neurotransmission. 19969287 2010
dbSNP: rs4251417
rs4251417
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
CUI: C0233514
Disease:
Abnormal behavior
0.010 GeneticVariation BEFREE SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p<sub>d</sub> = 9.25 × 10<sup>-03</sup>, p<sub>r</sub> = 7.24 × 10<sup>-03</sup>; rs2066713 p<sub>d</sub> = 6.35 × 10<sup>-08</sup>; rs25531 p<sub>d</sub> = 2.95 × 10<sup>-02</sup>; rs4251417 p<sub>d</sub> = 2.46 × 10<sup>-03</sup>), and ALZ (rs6354 p<sub>r</sub> = 1.22 × 10<sup>-02</sup>; rs7224199 p<sub>d</sub> = 1.00 × 10<sup>-08</sup>, p<sub>r</sub> = 2.65 × 10<sup>-02</sup>) cohorts. 31595439 2020
dbSNP: rs6354
rs6354
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
CUI: C0233514
Disease:
Abnormal behavior
0.010 GeneticVariation BEFREE SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p<sub>d</sub> = 9.25 × 10<sup>-03</sup>, p<sub>r</sub> = 7.24 × 10<sup>-03</sup>; rs2066713 p<sub>d</sub> = 6.35 × 10<sup>-08</sup>; rs25531 p<sub>d</sub> = 2.95 × 10<sup>-02</sup>; rs4251417 p<sub>d</sub> = 2.46 × 10<sup>-03</sup>), and ALZ (rs6354 p<sub>r</sub> = 1.22 × 10<sup>-02</sup>; rs7224199 p<sub>d</sub> = 1.00 × 10<sup>-08</sup>, p<sub>r</sub> = 2.65 × 10<sup>-02</sup>) cohorts. 31595439 2020
dbSNP: rs7224199
rs7224199
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
CUI: C0233514
Disease:
Abnormal behavior
0.010 GeneticVariation BEFREE SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p<sub>d</sub> = 9.25 × 10<sup>-03</sup>, p<sub>r</sub> = 7.24 × 10<sup>-03</sup>; rs2066713 p<sub>d</sub> = 6.35 × 10<sup>-08</sup>; rs25531 p<sub>d</sub> = 2.95 × 10<sup>-02</sup>; rs4251417 p<sub>d</sub> = 2.46 × 10<sup>-03</sup>), and ALZ (rs6354 p<sub>r</sub> = 1.22 × 10<sup>-02</sup>; rs7224199 p<sub>d</sub> = 1.00 × 10<sup>-08</sup>, p<sub>r</sub> = 2.65 × 10<sup>-02</sup>) cohorts. 31595439 2020
dbSNP: rs25531
rs25531
Entrez Id: 6532;105371720
Gene Symbol: SLC6A4;LOC105371720
SLC6A4;LOC105371720
CUI: C0001723
Disease:
Affective Disorders, Psychotic
0.010 GeneticVariation BEFREE Two polymorphisms in the 5-HTT gene (a 44 bp insertion/deletion in the promoter region and the functional polymorphism rs25531) were genotyped in a sample of 147 drug-naïve patients experiencing a first episode of a non-affective psychosis. 20031235 2010
dbSNP: rs25531
rs25531
Entrez Id: 6532;105371720
Gene Symbol: SLC6A4;LOC105371720
SLC6A4;LOC105371720
CUI: C0001973
Disease:
Alcoholic Intoxication, Chronic
0.020 GeneticVariation BEFREE SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p<sub>d</sub> = 9.25 × 10<sup>-03</sup>, p<sub>r</sub> = 7.24 × 10<sup>-03</sup>; rs2066713 p<sub>d</sub> = 6.35 × 10<sup>-08</sup>; rs25531 p<sub>d</sub> = 2.95 × 10<sup>-02</sup>; rs4251417 p<sub>d</sub> = 2.46 × 10<sup>-03</sup>), and ALZ (rs6354 p<sub>r</sub> = 1.22 × 10<sup>-02</sup>; rs7224199 p<sub>d</sub> = 1.00 × 10<sup>-08</sup>, p<sub>r</sub> = 2.65 × 10<sup>-02</sup>) cohorts. 31595439 2020
dbSNP: rs25531
rs25531
Entrez Id: 6532;105371720
Gene Symbol: SLC6A4;LOC105371720
SLC6A4;LOC105371720
CUI: C0001973
Disease:
Alcoholic Intoxication, Chronic
0.020 GeneticVariation BEFREE Comparing AD and control populations and taking into account statistical correction for multiple testing, we found no statistically significant differences for 5-HTTLPR (L/S) and rs25531 polymorphisms in terms of either genotypes or alleles frequencies. 25770138 2015
dbSNP: rs1042173
rs1042173
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
CUI: C0001973
Disease:
Alcoholic Intoxication, Chronic
0.010 GeneticVariation BEFREE Subsequent analysis of these two interaction models revealed an OR of 2.71 and 2.80, respectively, for AD (P < 0.001) in carriers of genotype combinations 5'-HTTLPR:LL/LS(SLC6A4)-rs1042173:TT/TG(SLC6A4)-rs1176744:AC(HTR3B)-rs3782025:AG(HTR3B) and 5'-HTTLPR:LL/LS(SLC6A4)-rs10160548:GT/TT(HTR3A)-rs1176744:AC(HTR3B)-rs3782025:AG(HTR3B). 23757001 2013
dbSNP: rs2066713
rs2066713
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
CUI: C0001973
Disease:
Alcoholic Intoxication, Chronic
0.010 GeneticVariation BEFREE SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p<sub>d</sub> = 9.25 × 10<sup>-03</sup>, p<sub>r</sub> = 7.24 × 10<sup>-03</sup>; rs2066713 p<sub>d</sub> = 6.35 × 10<sup>-08</sup>; rs25531 p<sub>d</sub> = 2.95 × 10<sup>-02</sup>; rs4251417 p<sub>d</sub> = 2.46 × 10<sup>-03</sup>), and ALZ (rs6354 p<sub>r</sub> = 1.22 × 10<sup>-02</sup>; rs7224199 p<sub>d</sub> = 1.00 × 10<sup>-08</sup>, p<sub>r</sub> = 2.65 × 10<sup>-02</sup>) cohorts. 31595439 2020
dbSNP: rs4251417
rs4251417
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
CUI: C0001973
Disease:
Alcoholic Intoxication, Chronic
0.010 GeneticVariation BEFREE SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p<sub>d</sub> = 9.25 × 10<sup>-03</sup>, p<sub>r</sub> = 7.24 × 10<sup>-03</sup>; rs2066713 p<sub>d</sub> = 6.35 × 10<sup>-08</sup>; rs25531 p<sub>d</sub> = 2.95 × 10<sup>-02</sup>; rs4251417 p<sub>d</sub> = 2.46 × 10<sup>-03</sup>), and ALZ (rs6354 p<sub>r</sub> = 1.22 × 10<sup>-02</sup>; rs7224199 p<sub>d</sub> = 1.00 × 10<sup>-08</sup>, p<sub>r</sub> = 2.65 × 10<sup>-02</sup>) cohorts. 31595439 2020
dbSNP: rs25531
rs25531
Entrez Id: 6532;105371720
Gene Symbol: SLC6A4;LOC105371720
SLC6A4;LOC105371720
CUI: C0002395
Disease:
Alzheimer's Disease
0.030 GeneticVariation BEFREE The distributions of 5-HTT-LPR and rs25531 polymorphisms in AD subjects were not different from those of controls. 27414430 2016
dbSNP: rs25531
rs25531
Entrez Id: 6532;105371720
Gene Symbol: SLC6A4;LOC105371720
SLC6A4;LOC105371720
CUI: C0002395
Disease:
Alzheimer's Disease
0.030 GeneticVariation BEFREE We conclude that 5-HTTLPR and rs25531 are not major genetic modulators of BPSD development in AD. 19625753 2009
dbSNP: rs25531
rs25531
Entrez Id: 6532;105371720
Gene Symbol: SLC6A4;LOC105371720
SLC6A4;LOC105371720
CUI: C0002395
Disease:
Alzheimer's Disease
0.030 GeneticVariation BEFREE SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p<sub>d</sub> = 9.25 × 10<sup>-03</sup>, p<sub>r</sub> = 7.24 × 10<sup>-03</sup>; rs2066713 p<sub>d</sub> = 6.35 × 10<sup>-08</sup>; rs25531 p<sub>d</sub> = 2.95 × 10<sup>-02</sup>; rs4251417 p<sub>d</sub> = 2.46 × 10<sup>-03</sup>), and ALZ (rs6354 p<sub>r</sub> = 1.22 × 10<sup>-02</sup>; rs7224199 p<sub>d</sub> = 1.00 × 10<sup>-08</sup>, p<sub>r</sub> = 2.65 × 10<sup>-02</sup>) cohorts. 31595439 2020
dbSNP: rs2066713
rs2066713
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
CUI: C0002395
Disease:
Alzheimer's Disease
0.010 GeneticVariation BEFREE SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p<sub>d</sub> = 9.25 × 10<sup>-03</sup>, p<sub>r</sub> = 7.24 × 10<sup>-03</sup>; rs2066713 p<sub>d</sub> = 6.35 × 10<sup>-08</sup>; rs25531 p<sub>d</sub> = 2.95 × 10<sup>-02</sup>; rs4251417 p<sub>d</sub> = 2.46 × 10<sup>-03</sup>), and ALZ (rs6354 p<sub>r</sub> = 1.22 × 10<sup>-02</sup>; rs7224199 p<sub>d</sub> = 1.00 × 10<sup>-08</sup>, p<sub>r</sub> = 2.65 × 10<sup>-02</sup>) cohorts. 31595439 2020
dbSNP: rs4251417
rs4251417
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
CUI: C0002395
Disease:
Alzheimer's Disease
0.010 GeneticVariation BEFREE SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p<sub>d</sub> = 9.25 × 10<sup>-03</sup>, p<sub>r</sub> = 7.24 × 10<sup>-03</sup>; rs2066713 p<sub>d</sub> = 6.35 × 10<sup>-08</sup>; rs25531 p<sub>d</sub> = 2.95 × 10<sup>-02</sup>; rs4251417 p<sub>d</sub> = 2.46 × 10<sup>-03</sup>), and ALZ (rs6354 p<sub>r</sub> = 1.22 × 10<sup>-02</sup>; rs7224199 p<sub>d</sub> = 1.00 × 10<sup>-08</sup>, p<sub>r</sub> = 2.65 × 10<sup>-02</sup>) cohorts. 31595439 2020
dbSNP: rs6354
rs6354
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
CUI: C0002395
Disease:
Alzheimer's Disease
0.010 GeneticVariation BEFREE SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p<sub>d</sub> = 9.25 × 10<sup>-03</sup>, p<sub>r</sub> = 7.24 × 10<sup>-03</sup>; rs2066713 p<sub>d</sub> = 6.35 × 10<sup>-08</sup>; rs25531 p<sub>d</sub> = 2.95 × 10<sup>-02</sup>; rs4251417 p<sub>d</sub> = 2.46 × 10<sup>-03</sup>), and ALZ (rs6354 p<sub>r</sub> = 1.22 × 10<sup>-02</sup>; rs7224199 p<sub>d</sub> = 1.00 × 10<sup>-08</sup>, p<sub>r</sub> = 2.65 × 10<sup>-02</sup>) cohorts. 31595439 2020
dbSNP: rs7224199
rs7224199
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
CUI: C0002395
Disease:
Alzheimer's Disease
0.010 GeneticVariation BEFREE SLC6A4 polymorphisms are not associated with the risk of developing major psychiatric disorders (SCZ and BPD); however some signals were detected in ALC (HTTLPR p<sub>d</sub> = 9.25 × 10<sup>-03</sup>, p<sub>r</sub> = 7.24 × 10<sup>-03</sup>; rs2066713 p<sub>d</sub> = 6.35 × 10<sup>-08</sup>; rs25531 p<sub>d</sub> = 2.95 × 10<sup>-02</sup>; rs4251417 p<sub>d</sub> = 2.46 × 10<sup>-03</sup>), and ALZ (rs6354 p<sub>r</sub> = 1.22 × 10<sup>-02</sup>; rs7224199 p<sub>d</sub> = 1.00 × 10<sup>-08</sup>, p<sub>r</sub> = 2.65 × 10<sup>-02</sup>) cohorts. 31595439 2020
dbSNP: rs1042173
rs1042173
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
CUI: C0522254
Disease:
Analgesic Overuse Headache
0.010 GeneticVariation BEFREE Although a minor contribution of SLC6A4 variants in the genetic liability of MOH cannot be excluded, haplotype-based analysis of STin2 VNTR and rs1042173T>G polymorphisms allowed to identify a subgroup of MOH patients with a higher number of monthly headache and, possibly, with a more severe disease. 21585624 2012
dbSNP: rs25531
rs25531
Entrez Id: 6532;105371720
Gene Symbol: SLC6A4;LOC105371720
SLC6A4;LOC105371720
CUI: C0178417
Disease:
Anhedonia
0.010 GeneticVariation BEFREE Although preliminary, these findings identify anhedonia as a promising mechanism linking 5-HTTLPR/rs25531 genotype and stress to depression. 22094432 2012